Cercar
01/05/2025
Diabetic patients with severe atherosclerosis display an exacerbated trained immune response characterized by an immunometabolic switch towards a prooxidative profile
Girón, G, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Borrell-Pagés, M, Oliveró, R, Martín-Grieve, S, Badimon, L, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Diabetic patients with severe atherosclerosis display an exacerbated trained immune response characterized by an immunometabolic switch towards a prooxidative profile. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Diabetic patients with atherosclerosis display a pro-atherogenic proteomic signature within the plasma-enriched high-density lipoprotein fraction
Girón, G, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Borrell-Pagés, M, Oliveró, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Diabetic patients with atherosclerosis display a pro-atherogenic proteomic signature within the plasma-enriched high-density lipoprotein fraction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/05/2025
Proton nuclear magnetic resonance characterization of lipoprotein particles in subjects with overweight and obesity
Santisteban, V, López-Yerena, A, Muñoz-Garcia, N, Vilahur, G, Badimon, L, Padro, T. Proton nuclear magnetic resonance characterization of lipoprotein particles in subjects with overweight and obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/12/2023
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases.
Benincasa G, Suades R, Padrò T, Badimon L, Napoli C. Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases.. European Heart Journal-Cardiovascular Pharmacotherapy. 2023; 9(8)DOI:10.1093/ehjcvp/pvad059. PMID:37562936. IF:(Q/D).
01/11/2023
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.
Cordero A, Fernández Olmo R, Badimon L, Santos-Gallego CG, Castellano JM, Fácila L, Rodriguez-Manero M, Bonanad C, Vilahur G, Escribano D, Badimon JJ, González-Juanatey JR. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.. Journal of Clinical Lipidology. 2023; 17(5)DOI:10.1016/j.jacl.2023.08.006. PMID:37775463. IF:3.600(Q2/3D).
01/01/2026
Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease
Girón, GO, Otero, S, Nikolaou, PE, Alcover, S, Ramos-Regalado, L, Zaragoza, C, Liberale, L, Borrell-Pages, M, Padró, T, Suades, R, Vilahur, G. Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70167. PMID:41482986. IF:3.600(Q1/2D).
01/05/2025
Canonical WNT pathway role in heart-brain axis after myocardial
Pimentel, N, Luquero, A, Vilahur, G, Borrel-Pages, M. Canonical WNT pathway role in heart-brain axis after myocardial. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55DOI:. PMID:. IF:3.600(Q1/2D).
01/01/2026
miRNA Expression Profile in Whole Blood of Healthy Volunteers and Moderate Beer Consumption with Meals
Padro, T, Escate, R, Badimon, L. miRNA Expression Profile in Whole Blood of Healthy Volunteers and Moderate Beer Consumption with Meals. Nutrients. 2026; 18(1)DOI:10.3390/nu18010149. PMID:41515265. IF:5.000(Q1/2D).